Evidence map›Paper›PMID 36146666›Full record

ReviewViruses2022

Can the COVID-19 Pandemic Improve the Management of Solid Organ Transplant Recipients?

Arnaud Del Bello, Olivier Marion, Jacques Izopet, Nassim Kamar

Open access · goldAbstract readReview
In one paragraph

Review in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Arnaud Del BelloDepartment of Nephrology and Organ Transplantation, Toulouse Rangueil University Hospital, 31059 Toulouse, France.
Olivier MarionDepartment of Nephrology and Organ Transplantation, Toulouse Rangueil University Hospital, 31059 Toulouse, France.ORCID 0000-0001-9702-1833
Jacques IzopetToulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR 1291, 31300 Toulouse, France.ORCID 0000-0002-8462-3234
Nassim KamarDepartment of Nephrology and Organ Transplantation, Toulouse Rangueil University Hospital, 31059 Toulouse, France.ORCID 0000-0003-1930-8964
Inserm · FRUniversité Toulouse III - Paul Sabatier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increased mortality due to SARS-CoV-2 infection was observed among solid organ transplant patients. During the pandemic, in order to prevent and treat COVID-19 infections in this context, several innovative procedures and therapies were initiated within a short period of time. A large number of these innovations can be applied and expanded to improve the management of non-COVID-19 infectious diseases in solid organ transplant patients and in the case of a future pandemic. In this vein, the present paper reviews and discusses medical care system adaptation, modification of immunosuppression, adjuvant innovative therapies, the role of laboratory expertise, and the prevention of infections as examples of such innovations.

Indexed as

COVID-19Organ TransplantationHumansPandemicsSARS-CoV-2Transplant RecipientsCOVID-19monoclonal antibodiesomicronorgan transplantationprevention

Identifiers

PMID36146666
PMCPMC9500961
OpenAlexW4293224678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.